Skip to content
Homepage
Author:
Zhejiang Difference Biological Technology Co., Ltd
Posted Date:
February 9, 2026
DIFF Biotech’s Innovative Nasal Spray Influenza Vaccine Receives Clinical Trial Approval, Introducing a New Attenuation Pathway
Zhejiang Difference Biological Technology Co., Ltd
February 9, 2026
